Literature DB >> 3300759

Effect of prostacyclin on the perfusion pressure and on the vasoconstrictor response of angiotensin II in the human isolated foetal placental circulation.

R Soares de Moura.   

Abstract

The effect of prostacyclin infusion on the perfusion pressure and on the vasoconstrictor response to three doses of angiotensin II was investigated in six full-term human placentas. The placentas were perfused with a modified Krebs-Henseleit solution and placenta perfusion pressure was recorded. Prostacyclin 5 X 10(-8) M, infused through the foetal placental circulation, produced a significant decrease in placental vascular resistance. The vasodepressor effect of prostacyclin persisted throughout the perfusion period and promptly disappeared when the infusion was stopped. The pressor response of angiotensin II was significantly reduced by prostacyclin infusion. These data suggest an interaction between the vascular effects of prostacyclin and angiotensin II on the placental circulation that might be important in the control of foetal placental blood flow.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300759      PMCID: PMC1386173          DOI: 10.1111/j.1365-2125.1987.tb03113.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Pressor response to angiotonin in pregnant and nonpregnant women.

Authors:  R ABDUL-KARIM; S ASSALIN
Journal:  Am J Obstet Gynecol       Date:  1961-08       Impact factor: 8.661

2.  The renin-angiotensin-aldosterone system in mother and fetus at term.

Authors:  C Godard; R Gaillard; M B Vallotton
Journal:  Nephron       Date:  1976       Impact factor: 2.847

3.  A study of angiotensin II pressor response throughout primigravid pregnancy.

Authors:  N F Gant; G L Daley; S Chand; P J Whalley; P C MacDonald
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

4.  Prostacyclin and human foetal circulation.

Authors:  G Remuzzi; R Misiani; D Muratore; D Marchesi; M Livio; A Schieppati; G Mecca; G de Gaetano; M B Donati
Journal:  Prostaglandins       Date:  1979-09

5.  Blood pressure survey in pregnancy.

Authors:  I MacGillivray; G A Rose; B Rowe
Journal:  Clin Sci       Date:  1969-10       Impact factor: 6.124

6.  Maternal vascular prostacyclin activity in pre-eclampsia.

Authors:  F Bussolino; C Benedetto; M Massobrio; G Camussi
Journal:  Lancet       Date:  1980-09-27       Impact factor: 79.321

7.  Prostacyclin in pregnancy.

Authors:  P J Lewis; P Boylan; L A Friedman; C N Hensby; I Downing
Journal:  Br Med J       Date:  1980-06-28

8.  Regional sensitivity to vasoactive polypeptides in the human umbilicoplacental vasculature.

Authors:  T N Tulenko
Journal:  Am J Obstet Gynecol       Date:  1979-11-01       Impact factor: 8.661

9.  Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia.

Authors:  G Remuzzi; D Marchesi; C Zoja; D Muratore; G Mecca; R Misiani; E Rossi; M Barbato; P Capetta; M B Donati; G de Gaetano
Journal:  Prostaglandins       Date:  1980-07

10.  Factors affecting angiotensin II concentrations in the human infant at birth.

Authors:  F Broughton Pipkin; E M Symonds
Journal:  Clin Sci Mol Med       Date:  1977-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.